(Q41598583)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Shanti Marlina Sibuea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

R A Rosalia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

E Varypataki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

F Ossendorp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

W Jiskoot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

7 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

847-854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576216%20AND%20SRC:MED&resulttype=core&format=json

Overview of vaccines and vaccination

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Cancer immunotherapy by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Virus-like particles induce robust human T-helper cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Improving protein therapeutics with sustained-release formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Programming the magnitude and persistence of antibody responses with innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Immunological mechanisms of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Innate immunity mediates follicular transport of particulate but not soluble protein antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Antigen kinetics determines immune reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

A Two-Stage Strategy for Sterilization of Poly(lactide-co-glycolide) Particles by γ-Irradiation Does Not Impair Their Potency for Vaccine Delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Biodegradable particles as vaccine delivery systems: size matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

LacZ inducible, antigen/MHC-specific T cell hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Targeting dendritic cells--why bother?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Pathogen recognition and development of particulate vaccines: does size matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Control of encapsulation efficiency and initial burst in polymeric microparticle systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Kinetics of drug release from polylactic acid-hydrocortisone microcapsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Innovative strategies for co-delivering antigens and CpG oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Lymphokine control of in vivo immunoglobulin isotype selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Protein instability in poly(lactic-co-glycolic acid) microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Heat denaturation of egg-white proteins abrogates the induction of oral tolerance of specific Th2 immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059

Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.059